Target intelligence / Profile preview

Extracellular matrix proteins and wound exudate components

Molecular classification
Other
01

Overview

Extracellular matrix (ECM) proteins and wound exudate components constitute the structural and fluid environment of the wound bed. The ECM is a complex network of proteins such as collagen, elastin, and fibronectin that provides physical scaffolding for cells and regulates biological processes like adhesion and migration (Source: NIH/NCBI). Wound exudate is the liquid produced by wounds that contains essential nutrients, growth factors, and immune cells necessary for healing (Source: PubMed). In chronic wounds, the balance of these components is often disrupted, leading to an overabundance of matrix metalloproteinases (MMPs) that prematurely degrade the ECM and inhibit tissue repair (Source: StatPearls). Therapeutic interventions often target these components through enzymatic debridement, such as using collagenase to remove necrotic tissue, or through advanced dressings that manage exudate levels and neutralize harmful proteases (Source: Journal of Wound Care). Understanding the interplay between the ECM and exudate is critical for developing treatments for non-healing ulcers and fibrotic conditions (Source: Nature Reviews Molecular Cell Biology). These components are not single molecular targets but rather a heterogeneous mixture of proteins and fluids that define the local physiological state of a wound. Drugs interacting with this environment often aim to restore homeostasis by either supplementing missing factors or removing inhibitory substances.

Other names
ECM proteinsWound fluidWound environmentInterstitial matrix
02

Mechanism of action

Enzymatic debridement of necrotic tissue, modulation of protease activity, and maintenance of a moist environment to facilitate autolytic debridement and granulation.

03

Biological functions

Cell adhesionStructural supportTissue remodelingSignal transductionInflammatory response
04

Disease associations

Chronic woundsFibrosisCancerInflammation
05

Safety considerations

Risk of periwound macerationPotential for hypersensitivity to biological componentsSecondary infection riskSystemic absorption of topical agents
06

Interacting drugs

Collagenase clostridium histolyticum

4 more in the full profile.

07

Biomarkers

Matrix metalloproteinases (MMPs)Interleukin-1 (IL-1)Tumor necrosis factor-alpha (TNF-alpha)C-reactive protein (CRP)

Beyond the preview

Go deeper on Extracellular matrix proteins and wound exudate components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix proteins and wound exudate components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call